cyc 202 has been researched along with Brain Injuries in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Byrnes, KR; Faden, AI; Hilton, GD; Stoica, BA | 1 |
Byrnes, KR; Faden, AI; Hanscom, M; Kabadi, SV; Loane, DJ; Stoica, BA | 1 |
2 other study(ies) available for cyc 202 and Brain Injuries
Article | Year |
---|---|
Roscovitine reduces neuronal loss, glial activation, and neurologic deficits after brain trauma.
Topics: Animals; Behavior, Animal; Brain Injuries; Cell Death; Cognition; Cyclin-Dependent Kinases; Immunohistochemistry; Male; Microglia; Motor Activity; Neurons; Neuroprotective Agents; Purines; Rats; Rats, Sprague-Dawley; Roscovitine | 2008 |
Selective CDK inhibitor limits neuroinflammation and progressive neurodegeneration after brain trauma.
Topics: Animals; Apoptosis; Behavior, Animal; Blotting, Western; Brain Injuries; Carrier Proteins; Cell Cycle; Cyclin A; Cyclin D1; Cyclin-Dependent Kinases; Disease Models, Animal; Immunohistochemistry; Maze Learning; Mice; Mice, Inbred C57BL; Microfilament Proteins; Microglia; Motor Activity; Neurons; Neuroprotective Agents; Purines; Roscovitine; Time Factors | 2012 |